Colgate-Palmolive (CL)
NYSE: CL
· Real-Time Price · USD
85.01
0.36 (0.43%)
At close: Aug 15, 2025, 3:59 PM
85.32
0.36%
After-hours: Aug 15, 2025, 07:48 PM EDT
Colgate-Palmolive Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.11B | 4.91B | 4.94B | 5.03B | 5.06B | 5.07B | 4.95B | 4.92B | 4.82B | 4.77B | 4.63B | 4.46B | 4.48B | 4.4B | 4.4B | 4.41B | 4.26B | 4.34B |
Cost of Revenue | 2.04B | 1.92B | 1.96B | 1.96B | 1.99B | 2.03B | 2.01B | 2.03B | 2.03B | 2.06B | 2.06B | 1.91B | 1.94B | 1.83B | 1.85B | 1.79B | 1.7B | 1.7B |
Gross Profit | 3.07B | 2.99B | 2.98B | 3.07B | 3.07B | 3.04B | 2.94B | 2.88B | 2.79B | 2.71B | 2.57B | 2.54B | 2.55B | 2.57B | 2.56B | 2.63B | 2.56B | 2.64B |
Operating Income | 1.11B | 1.09B | 1.09B | 1.11B | 1.16B | 1.18B | 1.14B | 1.06B | 1.04B | 953M | 938M | 913M | 904M | 989M | 959M | 989M | 992M | 1.03B |
Interest Income | 21M | 15M | 16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 1.01B | 953M | 994M | 986M | 1.01B | 967M | 988M | 956M | 887M | 561M | 132M | 892M | 841M | 795M | 324M | 853M | 953M | 957M |
Net Income | 743M | 690M | 739M | 737M | 731M | 683M | 718M | 708M | 502M | 372M | 5M | 618M | 603M | 559M | 148M | 634M | 703M | 681M |
Selling & General & Admin | 1.95B | 1.9B | 1.89B | 1.96B | 1.91B | 1.86B | 1.8B | 1.82B | 1.75B | 1.75B | 1.63B | 1.63B | 1.64B | 1.58B | 1.6B | 1.64B | 1.57B | 1.6B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.95B | 1.9B | 1.89B | 1.96B | 1.91B | 1.86B | 1.8B | 1.82B | 1.75B | 1.75B | 1.63B | 1.63B | 1.64B | 1.58B | 1.6B | 1.64B | 1.57B | 1.6B |
Interest Expense | 71M | 66M | 66M | 56M | 62M | 58M | 62M | 60M | 58M | 54M | 55M | 40M | 31M | 27M | 23M | 98M | 25M | 29M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4B | 3.82B | 3.85B | 3.92B | 3.9B | 3.89B | 3.81B | 3.85B | 3.78B | 3.82B | 3.69B | 3.54B | 3.58B | 3.41B | 3.44B | 3.42B | 3.27B | 3.31B |
Income Tax Expense | 234M | 227M | 214M | 210M | 243M | 238M | 228M | 209M | 353M | 147M | 89M | 210M | 202M | 192M | 136M | 172M | 212M | 229M |
Shares Outstanding (Basic) | 807.61M | 817.7M | 817.7M | 817.7M | 819.7M | 822.8M | 823.4M | 825.6M | 829.4M | 831.4M | 832.6M | 835.7M | 836.8M | 840.6M | 842.1M | 843.6M | 845.6M | 848.6M |
Shares Outstanding (Diluted) | 816.48M | 822.5M | 822.5M | 822.5M | 823.7M | 825.9M | 825.1M | 827.3M | 831.3M | 833M | 834.4M | 838.5M | 839.4M | 843.7M | 845M | 846.4M | 849.4M | 851.4M |
EPS (Basic) | 0.92 | 0.85 | 0.91 | 0.90 | 0.89 | 0.83 | 0.87 | 0.86 | 0.61 | 0.45 | 0.01 | 0.74 | 0.72 | 0.67 | 0.18 | 0.75 | 0.83 | 0.80 |
EPS (Diluted) | 0.91 | 0.85 | 0.90 | 0.90 | 0.89 | 0.83 | 0.87 | 0.86 | 0.60 | 0.45 | 0.01 | 0.74 | 0.72 | 0.66 | 0.18 | 0.75 | 0.83 | 0.80 |
EBITDA | 1.23B | 1.17B | 1.21B | 1.19B | 1.23B | 1.18B | 1.2B | 1.16B | 1.09B | 743M | 322M | 1.07B | 1.01B | 960M | 489M | 1.09B | 1.11B | 1.12B |
EBIT | 1.08B | 1.02B | 1.06B | 1.04B | 1.07B | 1.02B | 1.05B | 1.02B | 945M | 615M | 187M | 932M | 872M | 822M | 347M | 951M | 978M | 986M |
Depreciation & Amortization | 151M | 148M | 148M | 150M | 157M | 150M | 150M | 144M | 145M | 128M | 135M | 134M | 138M | 138M | 142M | 140M | 137M | 137M |